Report includes chapters which deeply display the following deliverable about industry :
• Opioids Market Research Objective and Assumption
• Opioids Market Purview - Report Description, Executive Summary, and Coherent Opportunity
Map (COM)
• Opioids Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory
Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain
Analysis, Porter’s Analysis, and PEST Analysis
• Global Opioids Market, By Regions
• Opioids Market Competition by Manufacturers including Production, Share, Revenue, Average
Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Opioids Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Opioids Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of
Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Opioids Market Forecast including Production, Consumption, Import and Export Forecast by
Type, Applications and Region.
• Research Findings and Conclusion
Increasing incidence of chronic pain is expected to drive the opioids market growth
Incidences of chronic pain is on the rise across the globe, with the rate being much higher in
developed economies such as the U.S., UK, Germany, and Canada. According to a study
published by BMJ (British Medical Journal), in 2013, around one-third to one-half of the
population in UK suffered from some kind of chronic pain. The situation is not quite different
in other developed economies such as the U.S. and Japan. According to a study published in
NCBI, in 2015, prevalence of chronic pain is estimated to be as high as 20% (one in five) in
Japan. The aging population is rapidly increasing in all in developed economies, which is thus
expected to further increase incidences of chronic pain, in turn increasing consumption of
opioid drugs.